Capvizr
THE DEAL, AT A GLANCE

Egyptian Biotech Reme-D

From the announcement
01What happenedEgyptian Biotech Reme-D raised $1.4M Pre-Series A, announced 2026-07-23From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersEgyptian Biotech Reme-D's $1.45M Pre-Series A indicates a small early-stage Healthcare & Life Sciences financing within an active sector funding tape, positioned below…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Egyptian Biotech Reme-D · Financing Record

Explore source-linked visual explanations for Egyptian Biotech Reme-D. Unsupported claims are withheld while source review continues.

Record 8794 · Recorded date: 2026-07-23

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime